The company’s financial performance for the year ending May 31, 2026, reflects a challenging environment. Reported net sales dipped 2.9% to $11.3 billion, while an adjusted operating margin of 11.3% highlighted the strain on profitability. Conagra’s fourth quarter was particularly impacted by $2 billion in impairment charges, a direct consequence of a sustained decline in the company’s market capitalization and stock price.

Looking toward fiscal 2027, management is setting conservative expectations. The company projects organic net sales to contract between 1% and 3%, with adjusted earnings per share forecasted in the $1.40 to $1.50 range. CEO John Brase, who recently took the helm, emphasized that the dividend reduction is a strategic move to enhance financial flexibility and increase capital investment in the company’s core supply chain and brand portfolio. While the firm successfully reduced its net debt to $7.1 billion—an 11.9% improvement over the prior year—the path to restoring growth remains tied to navigating ongoing inflationary pressures and stabilizing its diverse product categories.